世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

欧州バイオマテリアル市場予測 2022-2030


EUROPE BIOMATERIALS MARKET FORECAST 2022-2030

主な調査結果 欧州の生体材料市場は、予測期間である2022年から2030年にかけてCAGR12.62%で上昇すると予測されています。市場の成長は、高度で効果的な技術の採用による技術的な変革やヘルスケアエコシステムの... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Inkwood Research
インクウッドリサーチ
2022年4月11日 US$1,600
シングルユーザライセンス(印刷不可)
ライセンス・価格情報・注文方法はこちら
162 英語

 

サマリー

主な調査結果
欧州の生体材料市場は、予測期間である2022年から2030年にかけてCAGR12.62%で上昇すると予測されています。市場の成長は、高度で効果的な技術の採用による技術的な変革やヘルスケアエコシステムの変化によってもたらされると予測されます。
市場インサイト
欧州の生体材料市場の成長評価には、イタリア、ロシア、イギリス、ベルギー、フランス、ポーランド、ドイツ、その他の欧州の評価が含まれます。フランスでは、様々な組織が生体材料インプラントと組織工学の研究に注力しています。さらに、老人人口の増加、慢性疾患の有病率の急増、様々な研究機関の存在が、この地域の生体材料に対する需要を増加させることが分かっています。
さらに、イタリアの生体材料市場の成長は、整形外科、心臓血管、眼科、創傷治癒、歯科、形成外科、組織工学、神経・中枢神経系からの需要の増加によって刺激されます。しかし、この地域の市場は主要企業の存在感に欠けています。しかし、資金調達の増加や美容整形手術の採用に対する関心の高まりから、イタリアでは生体材料市場の成長が見込まれています。
また、ロシアは再生可能エネルギーが豊富で、消費者の層も広いため、バイオマテリアルを開発する上で非常に魅力的な市場となっています。ロシアで事業を展開する大手企業は、この地域で活動する幅広い消費者に対応するため、積極的なマーケティングとイノベーションの戦略に基づいています。ロシアにおける社会経済状況の改善と消費パターンの近代化も、同国のバイオマテリアルの需要を促進すると予想されます。
競争力のある洞察
市場における著名なプレーヤーとしては、Noble Biomaterials Inc、Royal DSM、BASF、三菱ケミカルホールディングス、Covestro AG、Collagen Solutions PLC、Zimmer Biomet Holdings Inc等が挙げられます。
当社のレポート提供内容は以下の通りです。
- 市場全体に関する主要な知見の調査
- 市場力学(推進要因、抑制要因、機会、課題)の戦略的なブレークダウン
- すべてのセグメント、サブセグメント、および地域の3年間の履歴データとともに、最低9年間の市場予測を行います。
- 市場セグメンテーションでは、主要なセグメントを徹底的に評価し、その市場推定を行います。
- 地域別分析。地域および国別セグメントの評価とその市場占有率
- 主要な分析ポーターの5つの力分析、ベンダーランドスケープ、オポチュニティマトリックス、キーバイヤークライテリア、など。
- コンペティティブ・ランドスケープは、主要企業を要因や市場シェアなどに基づいて理論的に説明したものです。
- 企業プロファイリング。詳細な企業概要、提供する製品/サービス、SCOT分析、最近の戦略的展開など


ページTOPに戻る


目次

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. USAGE OF BIOMATERIALS IN BONE FIXATION AND PLASTIC SURGERIES
3.1.2. PREVALENCE OF GERIATRIC POPULATION AND CARDIOVASCULAR DISEASES
3.1.3. GOVERNMENT SUPPORT FOR RESEARCH AND DEVELOPMENT INITIATIVES
3.1.4. APPLICATIONS OF BIOMATERIALS IN PLASTIC SURGERIES AND WOUND HEALING THERAPIES
3.2. KEY RESTRAINTS
3.2.1. BIOCOMPATIBILITY ISSUES ASSOCIATED WITH BIOMATERIAL
3.2.2. STRINGENT REGULATIONS
3.2.3. HIGH PRICE OF THE IMPLANTABLE BIOMATERIALS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON BIOMATERIALS MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
5. MARKET BY PRODUCT
5.1. METAL-BASED BIOMATERIALS
5.1.1. STAINLESS STEEL
5.1.2. TITANIUM AND TITANIUM ALLOYS
5.1.3. CO-CR ALLOYS
5.1.4. MAGNESIUM
5.1.5. GOLD
5.1.6. SILVER
5.1.7. NITINOL
5.1.8. OTHER METAL-BASED BIOMATERIALS
5.2. POLYMER-BASED BIOMATERIALS
5.2.1. PMMA
5.2.2. POLYETHYLENE TEREPHTHALATE
5.2.3. POLYESTER
5.2.4. POLYVINYLCHLORIDE
5.2.5. SILICONE RUBBER
5.2.6. NYLON
5.2.7. POLYETHERETHERKETONE
5.2.8. OTHER POLYMER-BASED BIOMATERIALS
5.3. CERAMIC-BASED BIOMATERIALS
5.3.1. CALCIUM PHOSPHATE
5.3.2. ALUMINUM OXIDE
5.3.3. CALCIUM SULFATE
5.3.4. ZIRCONIA
5.3.5. CARBON
5.3.6. GLASS
5.4. NATURAL BIOMATERIALS
5.4.1. HYALURONIC ACID
5.4.2. FIBRIN
5.4.3. COLLAGEN & GELATIN
5.4.4. CELLULOSE
5.4.5. CHITIN
5.4.6. ALGINATES
5.4.7. SILK
5.5. INORGANIC GLASS-BASED BIOMATERIALS
5.6. RADIOPAQUE BIOMATERIALS
5.7. REGENERATIVE BIOMATERIALS
5.8. HYBRID BIOMATERIAL COMBINATIONS
6. MARKET BY APPLICATION
6.1. CARDIOVASCULAR
6.1.1. CATHETERS
6.1.2. STENTS
6.1.3. HEART VALVES
6.1.4. PACEMAKERS
6.1.5. IMPLANTABLE CARDIAC DEFIBRILLATORS
6.1.6. VASCULAR GRAFTS
6.1.7. GUIDEWIRES
6.1.8. SENSORS
6.2. ORTHOPEDIC
6.2.1. JOINT REPLACEMENT
6.2.2. FRACTURE FIXATION
6.2.3. SPINE ADJUSTMENTS
6.2.4. ORTHOBIOLOGY
6.2.5. VISCOSUPPLEMENTATION
6.2.6. BIORESORBABLE TISSUE FIXATION
6.3. OPHTHALMOLOGY
6.3.1. CONTACT LENSES
6.3.2. INTRAOCULAR LENSES
6.3.3. FUNCTIONAL REPLACEMENT OF OCULAR TISSUES
6.3.4. SYNTHETIC CORNEAS
6.3.5. OTHER OPHTHALMOLOGY APPLICATIONS
6.4. DENTAL
6.4.1. DENTAL BONE GRAFTS AND SUBSTITUTES
6.4.2. DENTAL MEMBRANES
6.5. WOUND HEALING
6.5.1. STAPLES
6.5.2. WOUND CLOSURE DEVICES
6.5.3. SUTURES
6.5.4. HERNIA MESHES
6.5.5. SURGICAL HAEMOSTATS
6.5.6. INTERNAL TISSUE SEALANTS
6.5.7. ADHESION BARRIERS
6.6. PLASTIC SURGERIES
6.6.1. CRANIOFACIAL SURGERIES
6.6.2. SOFT-TISSUE FILLERS
6.7. NEUROLOGICAL/CENTRAL NERVOUS SYSTEM
6.7.1. SHUNTING SYSTEMS
6.7.2. NEURAL STEM CELL ENCAPSULATION
6.7.3. CORTICAL NEURAL PROSTHETICS (CNP)
6.7.4. HYDROGEL SCAFFOLDS
6.8. TISSUE ENGINEERING
6.8.1. TAILORING OF INORGANIC NANOPARTICLES
6.8.2. SCAFFOLDS FOR REGENERATIVE MEDICINES
6.8.3. NANOMATERIAL FOR BIOSENSING
6.9. OTHER APPLICATIONS
6.9.1. URINARY APPLICATIONS
6.9.2. DRUG DELIVERY SYSTEMS
6.9.3. BARIATRIC SURGERIES
6.9.4. GASTROINTESTINAL APPLICATIONS
7. GEOGRAPHICAL ANALYSIS
7.1. EUROPE
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. KEY GROWTH ENABLERS
7.1.3. KEY CHALLENGES
7.1.4. KEY PLAYERS
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED KINGDOM
7.1.5.2. GERMANY
7.1.5.3. FRANCE
7.1.5.4. ITALY
7.1.5.5. RUSSIA
7.1.5.6. BELGIUM
7.1.5.7. POLAND
7.1.5.8. REST OF EUROPE
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. BASF
8.2.2. BBS-BIOACTIVE BONE SUBSTITUTES
8.2.3. BIORETEC LTD
8.2.4. CARPENTER TECHNOLOGY CORPORATION
8.2.5. CELANESE CORPORATION
8.2.6. COLLAGEN SOLUTIONS PLC
8.2.7. CORBION NV
8.2.8. COVESTRO AG
8.2.9. DENTSPLY SIRONA
8.2.10. EVONIK INDUSTRIES
8.2.11. MITSUBISHI CHEMICAL HOLDINGS CORPORATION
8.2.12. NOBLE BIOMATERIALS INC
8.2.13. ROYAL DSM
8.2.14. VICTREX PLC
8.2.15. WRIGHT MEDICAL GROUP NV
8.2.16. ZIMMER BIOMET HOLDINGS INC






LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - BIOMATERIALS
TABLE 2: GERIATRIC POPULATION ACROSS DIFFERENT REGIONS (60 YEARS & ABOVE)
TABLE 3: EUROPE BIOMATERIALS MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 4: EUROPE BIOMATERIALS MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 5: EUROPE BIOMATERIALS MARKET, BY METAL-BASED BIOMATERIALS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: EUROPE BIOMATERIALS MARKET, BY METAL-BASED BIOMATERIALS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: EUROPE BIOMATERIALS MARKET, BY POLYMER-BASED BIOMATERIALS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: EUROPE BIOMATERIALS MARKET, BY POLYMER-BASED BIOMATERIALS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: EUROPE BIOMATERIALS MARKET, BY CERAMIC-BASED BIOMATERIALS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: EUROPE BIOMATERIALS MARKET, BY CERAMIC-BASED BIOMATERIALS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: EUROPE BIOMATERIALS MARKET, BY NATURAL BIOMATERIALS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: EUROPE BIOMATERIALS MARKET, BY NATURAL BIOMATERIALS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: EUROPE BIOMATERIALS MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: EUROPE BIOMATERIALS MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: EUROPE BIOMATERIALS MARKET, BY CARDIOVASCULAR, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 16: EUROPE BIOMATERIALS MARKET, BY CARDIOVASCULAR, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 17: EUROPE BIOMATERIALS MARKET, BY ORTHOPEDIC, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 18: EUROPE BIOMATERIALS MARKET, BY ORTHOPEDIC, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 19: EUROPE BIOMATERIALS MARKET, BY OPHTHALMOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 20: EUROPE BIOMATERIALS MARKET, BY OPHTHALMOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 21: EUROPE BIOMATERIALS MARKET, BY DENTAL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 22: EUROPE BIOMATERIALS MARKET, BY DENTAL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 23: EUROPE BIOMATERIALS MARKET, BY WOUND HEALING, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 24: EUROPE BIOMATERIALS MARKET, BY WOUND HEALING, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 25: EUROPE BIOMATERIALS MARKET, BY PLASTIC SURGERIES, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 26: EUROPE BIOMATERIALS MARKET, BY PLASTIC SURGERIES, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 27: EUROPE BIOMATERIALS MARKET, BY NEUROLOGICAL/CENTRAL NERVOUS SYSTEM, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 28: EUROPE BIOMATERIALS MARKET, BY NEUROLOGICAL/CENTRAL NERVOUS SYSTEM, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 29: EUROPE BIOMATERIALS MARKET, BY TISSUE ENGINEERING, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 30: EUROPE BIOMATERIALS MARKET, BY TISSUE ENGINEERING, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 31: EUROPE BIOMATERIALS MARKET, BY OTHER APPLICATIONS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 32: EUROPE BIOMATERIALS MARKET, BY OTHER APPLICATIONS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 33: EUROPE BIOMATERIALS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 34: EUROPE BIOMATERIALS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 35: LEADING PLAYERS OPERATING IN THE EUROPE BIOMATERIALS MARKET
TABLE 36: LIST OF MERGERS & ACQUISITIONS
TABLE 37: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 38: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 39: LIST OF BUSINESS EXPANSIONS & DIVESTITURES




LIST OF FIGURES
FIGURE 1: PLASTIC SURGERIES PROCEDURES PERFORMED IN VARIOUS COUNTRIES IN 2019
FIGURE 2: KEY MARKET TRENDS
FIGURE 3: PORTER’S FIVE FORCES ANALYSIS
FIGURE 4: OPPORTUNITY MATRIX
FIGURE 5: VENDOR LANDSCAPE
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
FIGURE 8: EUROPE BIOMATERIALS MARKET, BY METAL-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 9: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY METAL-BASED BIOMATERIALS, IN 2021
FIGURE 10: EUROPE BIOMATERIALS MARKET, BY STAINLESS STEEL, 2022-2030 (IN $ MILLION)
FIGURE 11: EUROPE BIOMATERIALS MARKET, BY TITANIUM AND TITANIUM ALLOYS, 2022-2030 (IN $ MILLION)
FIGURE 12: EUROPE BIOMATERIALS MARKET, BY CO-CR ALLOYS, 2022-2030 (IN $ MILLION)
FIGURE 13: EUROPE BIOMATERIALS MARKET, BY MAGNESIUM, 2022-2030 (IN $ MILLION)
FIGURE 14: EUROPE BIOMATERIALS MARKET, BY GOLD, 2022-2030 (IN $ MILLION)
FIGURE 15: EUROPE BIOMATERIALS MARKET, BY SILVER, 2022-2030 (IN $ MILLION)
FIGURE 16: EUROPE BIOMATERIALS MARKET, BY NITINOL, 2022-2030 (IN $ MILLION)
FIGURE 17: EUROPE BIOMATERIALS MARKET, BY OTHER METAL-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 18: EUROPE BIOMATERIALS MARKET, BY POLYMER-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 19: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY POLYMER-BASED BIOMATERIALS, IN 2021
FIGURE 20: EUROPE BIOMATERIALS MARKET, BY PMMA, 2022-2030 (IN $ MILLION)
FIGURE 21: EUROPE BIOMATERIALS MARKET, BY POLYETHYLENE TEREPHTHALATE, 2022-2030 (IN $ MILLION)
FIGURE 22: EUROPE BIOMATERIALS MARKET, BY POLYESTER, 2022-2030 (IN $ MILLION)
FIGURE 23: EUROPE BIOMATERIALS MARKET, BY POLYVINYLCHLORIDE, 2022-2030 (IN $ MILLION)
FIGURE 24: EUROPE BIOMATERIALS MARKET, BY SILICONE RUBBER, 2022-2030 (IN $ MILLION)
FIGURE 25: EUROPE BIOMATERIALS MARKET, BY NYLON, 2022-2030 (IN $ MILLION)
FIGURE 26: EUROPE BIOMATERIALS MARKET, BY POLYETHERETHERKETONE, 2022-2030 (IN $ MILLION)
FIGURE 27: EUROPE BIOMATERIALS MARKET, BY OTHER POLYMER-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 28: EUROPE BIOMATERIALS MARKET, BY CERAMIC-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 29: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY CERAMIC-BASED BIOMATERIALS, IN 2021
FIGURE 30: EUROPE BIOMATERIALS MARKET, BY CALCIUM PHOSPHATE, 2022-2030 (IN $ MILLION)
FIGURE 31: EUROPE BIOMATERIALS MARKET, BY ALUMINUM OXIDE, 2022-2030 (IN $ MILLION)
FIGURE 32: EUROPE BIOMATERIALS MARKET, BY CALCIUM SULFATE, 2022-2030 (IN $ MILLION)
FIGURE 33: EUROPE BIOMATERIALS MARKET, BY ZIRCONIA, 2022-2030 (IN $ MILLION)
FIGURE 34: EUROPE BIOMATERIALS MARKET, BY CARBON, 2022-2030 (IN $ MILLION)
FIGURE 35: EUROPE BIOMATERIALS MARKET, BY GLASS, 2022-2030 (IN $ MILLION)
FIGURE 36: EUROPE BIOMATERIALS MARKET, BY NATURAL BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 37: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY NATURAL BIOMATERIALS, IN 2021
FIGURE 38: EUROPE BIOMATERIALS MARKET, BY HYALURONIC ACID, 2022-2030 (IN $ MILLION)
FIGURE 39: EUROPE BIOMATERIALS MARKET, BY FIBRIN, 2022-2030 (IN $ MILLION)
FIGURE 40: EUROPE BIOMATERIALS MARKET, BY COLLAGEN & GELATIN, 2022-2030 (IN $ MILLION)
FIGURE 41: EUROPE BIOMATERIALS MARKET, BY CELLULOSE, 2022-2030 (IN $ MILLION)
FIGURE 42: EUROPE BIOMATERIALS MARKET, BY CHITIN, 2022-2030 (IN $ MILLION)
FIGURE 43: EUROPE BIOMATERIALS MARKET, BY ALGINATES, 2022-2030 (IN $ MILLION)
FIGURE 44: EUROPE BIOMATERIALS MARKET, BY SILK, 2022-2030 (IN $ MILLION)
FIGURE 45: EUROPE BIOMATERIALS MARKET, BY INORGANIC GLASS-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 46: EUROPE BIOMATERIALS MARKET, BY RADIOPAQUE BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 47: EUROPE BIOMATERIALS MARKET, BY REGENERATIVE BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 48: EUROPE BIOMATERIALS MARKET, BY HYBRID BIOMATERIAL COMBINATIONS, 2022-2030 (IN $ MILLION)
FIGURE 49: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 50: EUROPE BIOMATERIALS MARKET, BY CARDIOVASCULAR, 2022-2030 (IN $ MILLION)
FIGURE 51: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY CARDIOVASCULAR, IN 2021
FIGURE 52: EUROPE BIOMATERIALS MARKET, BY CATHETERS, 2022-2030 (IN $ MILLION)
FIGURE 53: EUROPE BIOMATERIALS MARKET, BY STENTS, 2022-2030 (IN $ MILLION)
FIGURE 54: EUROPE BIOMATERIALS MARKET, BY HEART VALVES, 2022-2030 (IN $ MILLION)
FIGURE 55: EUROPE BIOMATERIALS MARKET, BY PACEMAKERS, 2022-2030 (IN $ MILLION)
FIGURE 56: EUROPE BIOMATERIALS MARKET, BY IMPLANTABLE CARDIAC DEFIBRILLATORS, 2022-2030 (IN $ MILLION)
FIGURE 57: EUROPE BIOMATERIALS MARKET, BY VASCULAR GRAFTS, 2022-2030 (IN $ MILLION)
FIGURE 58: EUROPE BIOMATERIALS MARKET, BY GUIDEWIRES, 2022-2030 (IN $ MILLION)
FIGURE 59: EUROPE BIOMATERIALS MARKET, BY SENSORS, 2022-2030 (IN $ MILLION)
FIGURE 60: EUROPE BIOMATERIALS MARKET, BY ORTHOPEDIC, 2022-2030 (IN $ MILLION)
FIGURE 61: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY ORTHOPEDIC, IN 2021
FIGURE 62: EUROPE BIOMATERIALS MARKET, BY JOINT REPLACEMENT, 2022-2030 (IN $ MILLION)
FIGURE 63: EUROPE BIOMATERIALS MARKET, BY FRACTURE FIXATION, 2022-2030 (IN $ MILLION)
FIGURE 64: EUROPE BIOMATERIALS MARKET, BY SPINE ADJUSTMENTS, 2022-2030 (IN $ MILLION)
FIGURE 65: EUROPE BIOMATERIALS MARKET, BY ORTHOBIOLOGY, 2022-2030 (IN $ MILLION)
FIGURE 66: EUROPE BIOMATERIALS MARKET, BY VISCOSUPPLEMENTATION, 2022-2030 (IN $ MILLION)
FIGURE 67: EUROPE BIOMATERIALS MARKET, BY BIORESORBABLE TISSUE FIXATION, 2022-2030 (IN $ MILLION)
FIGURE 68: EUROPE BIOMATERIALS MARKET, BY OPHTHALMOLOGY, 2022-2030 (IN $ MILLION)
FIGURE 69: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY OPHTHALMOLOGY, IN 2021
FIGURE 70: EUROPE BIOMATERIALS MARKET, BY CONTACT LENSES, 2022-2030 (IN $ MILLION)
FIGURE 71: EUROPE BIOMATERIALS MARKET, BY INTRAOCULAR LENSES, 2022-2030 (IN $ MILLION)
FIGURE 72: EUROPE BIOMATERIALS MARKET, BY FUNCTIONAL REPLACEMENT OF OCULAR TISSUES, 2022-2030 (IN $ MILLION)
FIGURE 73: EUROPE BIOMATERIALS MARKET, BY SYNTHETIC CORNEAS, 2022-2030 (IN $ MILLION)
FIGURE 74: EUROPE BIOMATERIALS MARKET, BY OTHER OPHTHALMOLOGY APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 75: EUROPE BIOMATERIALS MARKET, BY DENTAL, 2022-2030 (IN $ MILLION)
FIGURE 76: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY DENTAL, IN 2021
FIGURE 77: EUROPE BIOMATERIALS MARKET, BY DENTAL BONE GRAFTS AND SUBSTITUTES, 2022-2030 (IN $ MILLION)
FIGURE 78: EUROPE BIOMATERIALS MARKET, BY DENTAL MEMBRANES, 2022-2030 (IN $ MILLION)
FIGURE 79: EUROPE BIOMATERIALS MARKET, BY WOUND HEALING, 2022-2030 (IN $ MILLION)
FIGURE 80: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY WOUND HEALING, IN 2021
FIGURE 81: EUROPE BIOMATERIALS MARKET, BY STAPLES, 2022-2030 (IN $ MILLION)
FIGURE 82: EUROPE BIOMATERIALS MARKET, BY WOUND CLOSURE DEVICES, 2022-2030 (IN $ MILLION)
FIGURE 83: EUROPE BIOMATERIALS MARKET, BY SUTURES, 2022-2030 (IN $ MILLION)
FIGURE 84: EUROPE BIOMATERIALS MARKET, BY HERNIA MESHES, 2022-2030 (IN $ MILLION)
FIGURE 85: EUROPE BIOMATERIALS MARKET, BY SURGICAL HAEMOSTATS, 2022-2030 (IN $ MILLION)
FIGURE 86: EUROPE BIOMATERIALS MARKET, BY INTERNAL TISSUE SEALANTS, 2022-2030 (IN $ MILLION)
FIGURE 87: EUROPE BIOMATERIALS MARKET, BY ADHESION BARRIERS, 2022-2030 (IN $ MILLION)
FIGURE 88: EUROPE BIOMATERIALS MARKET, BY PLASTIC SURGERIES, 2022-2030 (IN $ MILLION)
FIGURE 89: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY PLASTIC SURGERIES, IN 2021
FIGURE 90: EUROPE BIOMATERIALS MARKET, BY CRANIOFACIAL SURGERIES, 2022-2030 (IN $ MILLION)
FIGURE 91: EUROPE BIOMATERIALS MARKET, BY SOFT-TISSUE FILLERS, 2022-2030 (IN $ MILLION)
FIGURE 92: EUROPE BIOMATERIALS MARKET, BY NEUROLOGICAL/CENTRAL NERVOUS SYSTEM, 2022-2030 (IN $ MILLION)
FIGURE 93: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY NEUROLOGICAL/CENTRAL NERVOUS SYSTEM, IN 2021
FIGURE 94: EUROPE BIOMATERIALS MARKET, BY SHUNTING SYSTEMS, 2022-2030 (IN $ MILLION)
FIGURE 95: EUROPE BIOMATERIALS MARKET, BY NEURAL STEM CELL ENCAPSULATION, 2022-2030 (IN $ MILLION)
FIGURE 96: EUROPE BIOMATERIALS MARKET, BY CORTICAL NEURAL PROSTHETICS (CNP), 2022-2030 (IN $ MILLION)
FIGURE 97: EUROPE BIOMATERIALS MARKET, BY HYDROGEL SCAFFOLDS, 2022-2030 (IN $ MILLION)
FIGURE 98: EUROPE BIOMATERIALS MARKET, BY TISSUE ENGINEERING, 2022-2030 (IN $ MILLION)
FIGURE 99: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY TISSUE ENGINEERING, IN 2021
FIGURE 100: EUROPE BIOMATERIALS MARKET, BY TAILORING OF INORGANIC NANOPARTICLES, 2022-2030 (IN $ MILLION)
FIGURE 101: EUROPE BIOMATERIALS MARKET, BY SCAFFOLDS FOR REGENERATIVE MEDICINE, 2022-2030 (IN $ MILLION)
FIGURE 102: EUROPE BIOMATERIALS MARKET, BY NANOMATERIAL FOR BIOSENSING, 2022-2030 (IN $ MILLION)
FIGURE 103: EUROPE BIOMATERIALS MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 104: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY OTHER APPLICATIONS, IN 2021
FIGURE 105: EUROPE BIOMATERIALS MARKET, BY URINARY APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 106: EUROPE BIOMATERIALS MARKET, BY DRUG DELIVERY SYSTEMS, 2022-2030 (IN $ MILLION)
FIGURE 107: EUROPE BIOMATERIALS MARKET, BY BARIATRIC SURGERIES, 2022-2030 (IN $ MILLION)
FIGURE 108: EUROPE BIOMATERIALS MARKET, BY GASTROINTESTINAL APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 109: EUROPE BIOMATERIALS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 110: UNITED KINGDOM BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 111: GERMANY BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 112: FRANCE BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 113: ITALY BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 114: RUSSIA BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 115: BELGIUM BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 116: POLAND BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 117: REST OF EUROPE BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)

 

ページTOPに戻る


 

Summary

KEY FINDINGS
The Europe biomaterials market is estimated to rise with a CAGR of 12.62% during the forecast period, 2022-2030. The market growth is expected to be driven by technological transformations and changing healthcare ecosystems with the adoption of advanced and effective technologies.
MARKET INSIGHTS
The Europe biomaterials market growth evaluation entails the assessment of Italy, Russia, United Kingdom, Belgium, France, Poland, Germany, and Rest of Europe. In France, various organizations focus on researching biomaterial implants and tissue engineering. Moreover, the increasing geriatric population, the surge in prevalence of chronic diseases, and the presence of various research organizations are found to increase the demand for biomaterials in the region.
Furthermore, the Italy biomaterials market growth is stimulated by increasing demand from orthopedic, cardiovascular, ophthalmology, wound healing, dental, plastic surgery, tissue engineering, and neurological & central nervous system. However, the regional market lacks the presence of key players. But with increased funding and the rising interest in adopting cosmetic procedures, the biomaterials market is expected to grow in Italy.
In addition, Russia represents a very attractive market for developing biomaterials, given its extensive renewable energy assets and country-wide range of consumers. Major players operating in Russia are banking upon aggressive marketing and innovations strategies to cater to a wide range of consumers operating in the region. The improved socio-economic conditions and the modernization of consumption patterns in Russia are also anticipated to propel the demand for biomaterials in the country.
COMPETITIVE INSIGHTS
Some prominent market players in the market include Noble Biomaterials Inc, Royal DSM, BASF, Mitsubishi Chemical Holdings Corporation, Covestro AG, Collagen Solutions PLC, Zimmer Biomet Holdings Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. USAGE OF BIOMATERIALS IN BONE FIXATION AND PLASTIC SURGERIES
3.1.2. PREVALENCE OF GERIATRIC POPULATION AND CARDIOVASCULAR DISEASES
3.1.3. GOVERNMENT SUPPORT FOR RESEARCH AND DEVELOPMENT INITIATIVES
3.1.4. APPLICATIONS OF BIOMATERIALS IN PLASTIC SURGERIES AND WOUND HEALING THERAPIES
3.2. KEY RESTRAINTS
3.2.1. BIOCOMPATIBILITY ISSUES ASSOCIATED WITH BIOMATERIAL
3.2.2. STRINGENT REGULATIONS
3.2.3. HIGH PRICE OF THE IMPLANTABLE BIOMATERIALS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON BIOMATERIALS MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
5. MARKET BY PRODUCT
5.1. METAL-BASED BIOMATERIALS
5.1.1. STAINLESS STEEL
5.1.2. TITANIUM AND TITANIUM ALLOYS
5.1.3. CO-CR ALLOYS
5.1.4. MAGNESIUM
5.1.5. GOLD
5.1.6. SILVER
5.1.7. NITINOL
5.1.8. OTHER METAL-BASED BIOMATERIALS
5.2. POLYMER-BASED BIOMATERIALS
5.2.1. PMMA
5.2.2. POLYETHYLENE TEREPHTHALATE
5.2.3. POLYESTER
5.2.4. POLYVINYLCHLORIDE
5.2.5. SILICONE RUBBER
5.2.6. NYLON
5.2.7. POLYETHERETHERKETONE
5.2.8. OTHER POLYMER-BASED BIOMATERIALS
5.3. CERAMIC-BASED BIOMATERIALS
5.3.1. CALCIUM PHOSPHATE
5.3.2. ALUMINUM OXIDE
5.3.3. CALCIUM SULFATE
5.3.4. ZIRCONIA
5.3.5. CARBON
5.3.6. GLASS
5.4. NATURAL BIOMATERIALS
5.4.1. HYALURONIC ACID
5.4.2. FIBRIN
5.4.3. COLLAGEN & GELATIN
5.4.4. CELLULOSE
5.4.5. CHITIN
5.4.6. ALGINATES
5.4.7. SILK
5.5. INORGANIC GLASS-BASED BIOMATERIALS
5.6. RADIOPAQUE BIOMATERIALS
5.7. REGENERATIVE BIOMATERIALS
5.8. HYBRID BIOMATERIAL COMBINATIONS
6. MARKET BY APPLICATION
6.1. CARDIOVASCULAR
6.1.1. CATHETERS
6.1.2. STENTS
6.1.3. HEART VALVES
6.1.4. PACEMAKERS
6.1.5. IMPLANTABLE CARDIAC DEFIBRILLATORS
6.1.6. VASCULAR GRAFTS
6.1.7. GUIDEWIRES
6.1.8. SENSORS
6.2. ORTHOPEDIC
6.2.1. JOINT REPLACEMENT
6.2.2. FRACTURE FIXATION
6.2.3. SPINE ADJUSTMENTS
6.2.4. ORTHOBIOLOGY
6.2.5. VISCOSUPPLEMENTATION
6.2.6. BIORESORBABLE TISSUE FIXATION
6.3. OPHTHALMOLOGY
6.3.1. CONTACT LENSES
6.3.2. INTRAOCULAR LENSES
6.3.3. FUNCTIONAL REPLACEMENT OF OCULAR TISSUES
6.3.4. SYNTHETIC CORNEAS
6.3.5. OTHER OPHTHALMOLOGY APPLICATIONS
6.4. DENTAL
6.4.1. DENTAL BONE GRAFTS AND SUBSTITUTES
6.4.2. DENTAL MEMBRANES
6.5. WOUND HEALING
6.5.1. STAPLES
6.5.2. WOUND CLOSURE DEVICES
6.5.3. SUTURES
6.5.4. HERNIA MESHES
6.5.5. SURGICAL HAEMOSTATS
6.5.6. INTERNAL TISSUE SEALANTS
6.5.7. ADHESION BARRIERS
6.6. PLASTIC SURGERIES
6.6.1. CRANIOFACIAL SURGERIES
6.6.2. SOFT-TISSUE FILLERS
6.7. NEUROLOGICAL/CENTRAL NERVOUS SYSTEM
6.7.1. SHUNTING SYSTEMS
6.7.2. NEURAL STEM CELL ENCAPSULATION
6.7.3. CORTICAL NEURAL PROSTHETICS (CNP)
6.7.4. HYDROGEL SCAFFOLDS
6.8. TISSUE ENGINEERING
6.8.1. TAILORING OF INORGANIC NANOPARTICLES
6.8.2. SCAFFOLDS FOR REGENERATIVE MEDICINES
6.8.3. NANOMATERIAL FOR BIOSENSING
6.9. OTHER APPLICATIONS
6.9.1. URINARY APPLICATIONS
6.9.2. DRUG DELIVERY SYSTEMS
6.9.3. BARIATRIC SURGERIES
6.9.4. GASTROINTESTINAL APPLICATIONS
7. GEOGRAPHICAL ANALYSIS
7.1. EUROPE
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. KEY GROWTH ENABLERS
7.1.3. KEY CHALLENGES
7.1.4. KEY PLAYERS
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED KINGDOM
7.1.5.2. GERMANY
7.1.5.3. FRANCE
7.1.5.4. ITALY
7.1.5.5. RUSSIA
7.1.5.6. BELGIUM
7.1.5.7. POLAND
7.1.5.8. REST OF EUROPE
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. BASF
8.2.2. BBS-BIOACTIVE BONE SUBSTITUTES
8.2.3. BIORETEC LTD
8.2.4. CARPENTER TECHNOLOGY CORPORATION
8.2.5. CELANESE CORPORATION
8.2.6. COLLAGEN SOLUTIONS PLC
8.2.7. CORBION NV
8.2.8. COVESTRO AG
8.2.9. DENTSPLY SIRONA
8.2.10. EVONIK INDUSTRIES
8.2.11. MITSUBISHI CHEMICAL HOLDINGS CORPORATION
8.2.12. NOBLE BIOMATERIALS INC
8.2.13. ROYAL DSM
8.2.14. VICTREX PLC
8.2.15. WRIGHT MEDICAL GROUP NV
8.2.16. ZIMMER BIOMET HOLDINGS INC






LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - BIOMATERIALS
TABLE 2: GERIATRIC POPULATION ACROSS DIFFERENT REGIONS (60 YEARS & ABOVE)
TABLE 3: EUROPE BIOMATERIALS MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 4: EUROPE BIOMATERIALS MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 5: EUROPE BIOMATERIALS MARKET, BY METAL-BASED BIOMATERIALS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: EUROPE BIOMATERIALS MARKET, BY METAL-BASED BIOMATERIALS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: EUROPE BIOMATERIALS MARKET, BY POLYMER-BASED BIOMATERIALS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: EUROPE BIOMATERIALS MARKET, BY POLYMER-BASED BIOMATERIALS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: EUROPE BIOMATERIALS MARKET, BY CERAMIC-BASED BIOMATERIALS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: EUROPE BIOMATERIALS MARKET, BY CERAMIC-BASED BIOMATERIALS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: EUROPE BIOMATERIALS MARKET, BY NATURAL BIOMATERIALS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: EUROPE BIOMATERIALS MARKET, BY NATURAL BIOMATERIALS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: EUROPE BIOMATERIALS MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: EUROPE BIOMATERIALS MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: EUROPE BIOMATERIALS MARKET, BY CARDIOVASCULAR, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 16: EUROPE BIOMATERIALS MARKET, BY CARDIOVASCULAR, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 17: EUROPE BIOMATERIALS MARKET, BY ORTHOPEDIC, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 18: EUROPE BIOMATERIALS MARKET, BY ORTHOPEDIC, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 19: EUROPE BIOMATERIALS MARKET, BY OPHTHALMOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 20: EUROPE BIOMATERIALS MARKET, BY OPHTHALMOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 21: EUROPE BIOMATERIALS MARKET, BY DENTAL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 22: EUROPE BIOMATERIALS MARKET, BY DENTAL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 23: EUROPE BIOMATERIALS MARKET, BY WOUND HEALING, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 24: EUROPE BIOMATERIALS MARKET, BY WOUND HEALING, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 25: EUROPE BIOMATERIALS MARKET, BY PLASTIC SURGERIES, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 26: EUROPE BIOMATERIALS MARKET, BY PLASTIC SURGERIES, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 27: EUROPE BIOMATERIALS MARKET, BY NEUROLOGICAL/CENTRAL NERVOUS SYSTEM, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 28: EUROPE BIOMATERIALS MARKET, BY NEUROLOGICAL/CENTRAL NERVOUS SYSTEM, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 29: EUROPE BIOMATERIALS MARKET, BY TISSUE ENGINEERING, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 30: EUROPE BIOMATERIALS MARKET, BY TISSUE ENGINEERING, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 31: EUROPE BIOMATERIALS MARKET, BY OTHER APPLICATIONS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 32: EUROPE BIOMATERIALS MARKET, BY OTHER APPLICATIONS, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 33: EUROPE BIOMATERIALS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 34: EUROPE BIOMATERIALS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 35: LEADING PLAYERS OPERATING IN THE EUROPE BIOMATERIALS MARKET
TABLE 36: LIST OF MERGERS & ACQUISITIONS
TABLE 37: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 38: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 39: LIST OF BUSINESS EXPANSIONS & DIVESTITURES




LIST OF FIGURES
FIGURE 1: PLASTIC SURGERIES PROCEDURES PERFORMED IN VARIOUS COUNTRIES IN 2019
FIGURE 2: KEY MARKET TRENDS
FIGURE 3: PORTER’S FIVE FORCES ANALYSIS
FIGURE 4: OPPORTUNITY MATRIX
FIGURE 5: VENDOR LANDSCAPE
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
FIGURE 8: EUROPE BIOMATERIALS MARKET, BY METAL-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 9: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY METAL-BASED BIOMATERIALS, IN 2021
FIGURE 10: EUROPE BIOMATERIALS MARKET, BY STAINLESS STEEL, 2022-2030 (IN $ MILLION)
FIGURE 11: EUROPE BIOMATERIALS MARKET, BY TITANIUM AND TITANIUM ALLOYS, 2022-2030 (IN $ MILLION)
FIGURE 12: EUROPE BIOMATERIALS MARKET, BY CO-CR ALLOYS, 2022-2030 (IN $ MILLION)
FIGURE 13: EUROPE BIOMATERIALS MARKET, BY MAGNESIUM, 2022-2030 (IN $ MILLION)
FIGURE 14: EUROPE BIOMATERIALS MARKET, BY GOLD, 2022-2030 (IN $ MILLION)
FIGURE 15: EUROPE BIOMATERIALS MARKET, BY SILVER, 2022-2030 (IN $ MILLION)
FIGURE 16: EUROPE BIOMATERIALS MARKET, BY NITINOL, 2022-2030 (IN $ MILLION)
FIGURE 17: EUROPE BIOMATERIALS MARKET, BY OTHER METAL-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 18: EUROPE BIOMATERIALS MARKET, BY POLYMER-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 19: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY POLYMER-BASED BIOMATERIALS, IN 2021
FIGURE 20: EUROPE BIOMATERIALS MARKET, BY PMMA, 2022-2030 (IN $ MILLION)
FIGURE 21: EUROPE BIOMATERIALS MARKET, BY POLYETHYLENE TEREPHTHALATE, 2022-2030 (IN $ MILLION)
FIGURE 22: EUROPE BIOMATERIALS MARKET, BY POLYESTER, 2022-2030 (IN $ MILLION)
FIGURE 23: EUROPE BIOMATERIALS MARKET, BY POLYVINYLCHLORIDE, 2022-2030 (IN $ MILLION)
FIGURE 24: EUROPE BIOMATERIALS MARKET, BY SILICONE RUBBER, 2022-2030 (IN $ MILLION)
FIGURE 25: EUROPE BIOMATERIALS MARKET, BY NYLON, 2022-2030 (IN $ MILLION)
FIGURE 26: EUROPE BIOMATERIALS MARKET, BY POLYETHERETHERKETONE, 2022-2030 (IN $ MILLION)
FIGURE 27: EUROPE BIOMATERIALS MARKET, BY OTHER POLYMER-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 28: EUROPE BIOMATERIALS MARKET, BY CERAMIC-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 29: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY CERAMIC-BASED BIOMATERIALS, IN 2021
FIGURE 30: EUROPE BIOMATERIALS MARKET, BY CALCIUM PHOSPHATE, 2022-2030 (IN $ MILLION)
FIGURE 31: EUROPE BIOMATERIALS MARKET, BY ALUMINUM OXIDE, 2022-2030 (IN $ MILLION)
FIGURE 32: EUROPE BIOMATERIALS MARKET, BY CALCIUM SULFATE, 2022-2030 (IN $ MILLION)
FIGURE 33: EUROPE BIOMATERIALS MARKET, BY ZIRCONIA, 2022-2030 (IN $ MILLION)
FIGURE 34: EUROPE BIOMATERIALS MARKET, BY CARBON, 2022-2030 (IN $ MILLION)
FIGURE 35: EUROPE BIOMATERIALS MARKET, BY GLASS, 2022-2030 (IN $ MILLION)
FIGURE 36: EUROPE BIOMATERIALS MARKET, BY NATURAL BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 37: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY NATURAL BIOMATERIALS, IN 2021
FIGURE 38: EUROPE BIOMATERIALS MARKET, BY HYALURONIC ACID, 2022-2030 (IN $ MILLION)
FIGURE 39: EUROPE BIOMATERIALS MARKET, BY FIBRIN, 2022-2030 (IN $ MILLION)
FIGURE 40: EUROPE BIOMATERIALS MARKET, BY COLLAGEN & GELATIN, 2022-2030 (IN $ MILLION)
FIGURE 41: EUROPE BIOMATERIALS MARKET, BY CELLULOSE, 2022-2030 (IN $ MILLION)
FIGURE 42: EUROPE BIOMATERIALS MARKET, BY CHITIN, 2022-2030 (IN $ MILLION)
FIGURE 43: EUROPE BIOMATERIALS MARKET, BY ALGINATES, 2022-2030 (IN $ MILLION)
FIGURE 44: EUROPE BIOMATERIALS MARKET, BY SILK, 2022-2030 (IN $ MILLION)
FIGURE 45: EUROPE BIOMATERIALS MARKET, BY INORGANIC GLASS-BASED BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 46: EUROPE BIOMATERIALS MARKET, BY RADIOPAQUE BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 47: EUROPE BIOMATERIALS MARKET, BY REGENERATIVE BIOMATERIALS, 2022-2030 (IN $ MILLION)
FIGURE 48: EUROPE BIOMATERIALS MARKET, BY HYBRID BIOMATERIAL COMBINATIONS, 2022-2030 (IN $ MILLION)
FIGURE 49: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 50: EUROPE BIOMATERIALS MARKET, BY CARDIOVASCULAR, 2022-2030 (IN $ MILLION)
FIGURE 51: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY CARDIOVASCULAR, IN 2021
FIGURE 52: EUROPE BIOMATERIALS MARKET, BY CATHETERS, 2022-2030 (IN $ MILLION)
FIGURE 53: EUROPE BIOMATERIALS MARKET, BY STENTS, 2022-2030 (IN $ MILLION)
FIGURE 54: EUROPE BIOMATERIALS MARKET, BY HEART VALVES, 2022-2030 (IN $ MILLION)
FIGURE 55: EUROPE BIOMATERIALS MARKET, BY PACEMAKERS, 2022-2030 (IN $ MILLION)
FIGURE 56: EUROPE BIOMATERIALS MARKET, BY IMPLANTABLE CARDIAC DEFIBRILLATORS, 2022-2030 (IN $ MILLION)
FIGURE 57: EUROPE BIOMATERIALS MARKET, BY VASCULAR GRAFTS, 2022-2030 (IN $ MILLION)
FIGURE 58: EUROPE BIOMATERIALS MARKET, BY GUIDEWIRES, 2022-2030 (IN $ MILLION)
FIGURE 59: EUROPE BIOMATERIALS MARKET, BY SENSORS, 2022-2030 (IN $ MILLION)
FIGURE 60: EUROPE BIOMATERIALS MARKET, BY ORTHOPEDIC, 2022-2030 (IN $ MILLION)
FIGURE 61: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY ORTHOPEDIC, IN 2021
FIGURE 62: EUROPE BIOMATERIALS MARKET, BY JOINT REPLACEMENT, 2022-2030 (IN $ MILLION)
FIGURE 63: EUROPE BIOMATERIALS MARKET, BY FRACTURE FIXATION, 2022-2030 (IN $ MILLION)
FIGURE 64: EUROPE BIOMATERIALS MARKET, BY SPINE ADJUSTMENTS, 2022-2030 (IN $ MILLION)
FIGURE 65: EUROPE BIOMATERIALS MARKET, BY ORTHOBIOLOGY, 2022-2030 (IN $ MILLION)
FIGURE 66: EUROPE BIOMATERIALS MARKET, BY VISCOSUPPLEMENTATION, 2022-2030 (IN $ MILLION)
FIGURE 67: EUROPE BIOMATERIALS MARKET, BY BIORESORBABLE TISSUE FIXATION, 2022-2030 (IN $ MILLION)
FIGURE 68: EUROPE BIOMATERIALS MARKET, BY OPHTHALMOLOGY, 2022-2030 (IN $ MILLION)
FIGURE 69: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY OPHTHALMOLOGY, IN 2021
FIGURE 70: EUROPE BIOMATERIALS MARKET, BY CONTACT LENSES, 2022-2030 (IN $ MILLION)
FIGURE 71: EUROPE BIOMATERIALS MARKET, BY INTRAOCULAR LENSES, 2022-2030 (IN $ MILLION)
FIGURE 72: EUROPE BIOMATERIALS MARKET, BY FUNCTIONAL REPLACEMENT OF OCULAR TISSUES, 2022-2030 (IN $ MILLION)
FIGURE 73: EUROPE BIOMATERIALS MARKET, BY SYNTHETIC CORNEAS, 2022-2030 (IN $ MILLION)
FIGURE 74: EUROPE BIOMATERIALS MARKET, BY OTHER OPHTHALMOLOGY APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 75: EUROPE BIOMATERIALS MARKET, BY DENTAL, 2022-2030 (IN $ MILLION)
FIGURE 76: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY DENTAL, IN 2021
FIGURE 77: EUROPE BIOMATERIALS MARKET, BY DENTAL BONE GRAFTS AND SUBSTITUTES, 2022-2030 (IN $ MILLION)
FIGURE 78: EUROPE BIOMATERIALS MARKET, BY DENTAL MEMBRANES, 2022-2030 (IN $ MILLION)
FIGURE 79: EUROPE BIOMATERIALS MARKET, BY WOUND HEALING, 2022-2030 (IN $ MILLION)
FIGURE 80: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY WOUND HEALING, IN 2021
FIGURE 81: EUROPE BIOMATERIALS MARKET, BY STAPLES, 2022-2030 (IN $ MILLION)
FIGURE 82: EUROPE BIOMATERIALS MARKET, BY WOUND CLOSURE DEVICES, 2022-2030 (IN $ MILLION)
FIGURE 83: EUROPE BIOMATERIALS MARKET, BY SUTURES, 2022-2030 (IN $ MILLION)
FIGURE 84: EUROPE BIOMATERIALS MARKET, BY HERNIA MESHES, 2022-2030 (IN $ MILLION)
FIGURE 85: EUROPE BIOMATERIALS MARKET, BY SURGICAL HAEMOSTATS, 2022-2030 (IN $ MILLION)
FIGURE 86: EUROPE BIOMATERIALS MARKET, BY INTERNAL TISSUE SEALANTS, 2022-2030 (IN $ MILLION)
FIGURE 87: EUROPE BIOMATERIALS MARKET, BY ADHESION BARRIERS, 2022-2030 (IN $ MILLION)
FIGURE 88: EUROPE BIOMATERIALS MARKET, BY PLASTIC SURGERIES, 2022-2030 (IN $ MILLION)
FIGURE 89: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY PLASTIC SURGERIES, IN 2021
FIGURE 90: EUROPE BIOMATERIALS MARKET, BY CRANIOFACIAL SURGERIES, 2022-2030 (IN $ MILLION)
FIGURE 91: EUROPE BIOMATERIALS MARKET, BY SOFT-TISSUE FILLERS, 2022-2030 (IN $ MILLION)
FIGURE 92: EUROPE BIOMATERIALS MARKET, BY NEUROLOGICAL/CENTRAL NERVOUS SYSTEM, 2022-2030 (IN $ MILLION)
FIGURE 93: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY NEUROLOGICAL/CENTRAL NERVOUS SYSTEM, IN 2021
FIGURE 94: EUROPE BIOMATERIALS MARKET, BY SHUNTING SYSTEMS, 2022-2030 (IN $ MILLION)
FIGURE 95: EUROPE BIOMATERIALS MARKET, BY NEURAL STEM CELL ENCAPSULATION, 2022-2030 (IN $ MILLION)
FIGURE 96: EUROPE BIOMATERIALS MARKET, BY CORTICAL NEURAL PROSTHETICS (CNP), 2022-2030 (IN $ MILLION)
FIGURE 97: EUROPE BIOMATERIALS MARKET, BY HYDROGEL SCAFFOLDS, 2022-2030 (IN $ MILLION)
FIGURE 98: EUROPE BIOMATERIALS MARKET, BY TISSUE ENGINEERING, 2022-2030 (IN $ MILLION)
FIGURE 99: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY TISSUE ENGINEERING, IN 2021
FIGURE 100: EUROPE BIOMATERIALS MARKET, BY TAILORING OF INORGANIC NANOPARTICLES, 2022-2030 (IN $ MILLION)
FIGURE 101: EUROPE BIOMATERIALS MARKET, BY SCAFFOLDS FOR REGENERATIVE MEDICINE, 2022-2030 (IN $ MILLION)
FIGURE 102: EUROPE BIOMATERIALS MARKET, BY NANOMATERIAL FOR BIOSENSING, 2022-2030 (IN $ MILLION)
FIGURE 103: EUROPE BIOMATERIALS MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 104: EUROPE BIOMATERIALS MARKET, GROWTH POTENTIAL, BY OTHER APPLICATIONS, IN 2021
FIGURE 105: EUROPE BIOMATERIALS MARKET, BY URINARY APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 106: EUROPE BIOMATERIALS MARKET, BY DRUG DELIVERY SYSTEMS, 2022-2030 (IN $ MILLION)
FIGURE 107: EUROPE BIOMATERIALS MARKET, BY BARIATRIC SURGERIES, 2022-2030 (IN $ MILLION)
FIGURE 108: EUROPE BIOMATERIALS MARKET, BY GASTROINTESTINAL APPLICATIONS, 2022-2030 (IN $ MILLION)
FIGURE 109: EUROPE BIOMATERIALS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 110: UNITED KINGDOM BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 111: GERMANY BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 112: FRANCE BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 113: ITALY BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 114: RUSSIA BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 115: BELGIUM BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 116: POLAND BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 117: REST OF EUROPE BIOMATERIALS MARKET, 2022-2030 (IN $ MILLION)

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Inkwood Research社はどのような調査会社ですか?


Inkwood Researchは世界40ヶ国以上の国を対象に広範な市場を調査し、世界市場全体を調査したレポートに加え、アジア太平洋地域、欧州、北米などの主要地域や主要国毎のレポートも数多く出版してい... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/10/18 10:26

151.13 円

164.11 円

199.39 円

ページTOPに戻る